Home / Stocks / COLINZ
Back to all stocks
BSE · COLINZ

Colinz Laboratories ltd. (COLINZ) Share Price

Sector: Healthcare · ISIN: INE923C01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,249
of 5,047 stocks
▼ 231W▼ 401M
Peak #4,110 · 02 Oct 2026

Colinz Laboratories ltd., a microcap Healthcare business, is seeing revenue slip, commands a premium earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap
17.00 Cr
P/E Ratio
33.09
P/B Ratio
1.69
ROE
5.12%
ROCE
7.20%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue1.55 Cr1.24 Cr1.75 Cr1.43 Cr
Net Profit12.65 L2.40 Cr17.12 L8.36 L
EPS0.509.53—0.33
Operating Profit20.20 L14.52 L5.19 L13.74 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
50.60%
Public
49.40%

PUBLIC BREAKDOWN

Individuals
46.77%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs